查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1772231

美国过敏诊断与治疗市场：市场规模、份额、趋势分析（按类型、过敏原类型和测试类型）、细分市场预测（2025-2030 年）

U.S. Allergy Diagnostics & Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug, & Other Allergens), By Test Type, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

美国过敏诊断和治疗市场规模预计在2024年达到108.6亿美元，2025年至2030年的复合年增长率为6.8%。推动这一市场发展的因素包括人群中过敏症盛行率的不断上升，以及污染加剧和生活方式改变等环境因素对先进解决方案的需求。美国过敏诊断和治疗产业正经历着向精准诊断的转变。这项转变的动力源自于分子过敏学的突破性创新以及数位健康工具的广泛应用。

各公司正积极扩展其过敏检测产品组合，并专注于能够同时从单一检体中检测多种过敏原的多重检测。此外，这些诊断平台越来越多地被设计为与电子健康记录(EHR) 无缝集成，这是促进全面患者资料管理和增强临床决策的关键进步。

该行业的特点是高度创新，这得益于持续的研发、技术进步以及更有效的诊断和治疗方法的开发。 2025年4月，贝克曼库尔特生命科学部宣布推出其下一代嗜碱性粒细胞活化测试（BAT），仅用于研究目的，以加速和改进过敏研究。

美国过敏诊断和治疗行业的特点是，大量新产品的推出、策略联盟的建立以及主要企业之间的收购，重点在于提高诊断的准确性和治疗效果。 2024年1月，Inimmune Corporation 和 Intrommune Therapeutics 宣布建立策略联盟，共同开发突破性的花生过敏口腔黏膜免疫疗法。

目录

第一章 分析方法与范围

第二章执行摘要

第三章美国过敏诊断与治疗市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 美国过敏诊断与治疗市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析
  • 美国过敏诊断与治疗市场：渠道分析

第四章美国过敏诊断和治疗市场：按类型估计和趋势分析

  • 细分仪表板：按类型
  • 美国过敏诊断与治疗市场：按类型变化分析
  • 美国过敏诊断及治疗市场规模及趋势分析（2018-2030）
  • 诊断
    • 装置
    • 耗材
    • 服务
  • 治疗
    • 抗组织胺药
    • 鼻减充血剂
    • 皮质类固醇
    • 肥大细胞稳定剂
    • 白三烯抑制剂
    • 鼻用抗胆碱药物
    • 免疫调节剂
    • 肾上腺素
    • 免疫疗法

第五章美国过敏诊断和治疗市场：按过敏原类型进行的估计和趋势分析

  • 细分仪表板：依过敏原类型
  • 美国过敏诊断与治疗市场：按过敏原类型变化分析
  • 美国过敏诊断及治疗市场规模及过敏原类型趋势分析（2018-2030）
  • 食物
    • 乳製品
    • 家禽产品
    • 坚果
    • 花生
    • 贝类
    • 小麦
    • 大豆
    • 其他食物过敏原
  • 吸入
  • 药物
  • 其他过敏原

第六章美国过敏诊断和治疗市场：按测试类型进行的估计和趋势分析

  • 细分仪表板：依测试类型
  • 美国过敏诊断与治疗市场：按测试类型变化分析
  • 美国过敏诊断及治疗市场规模及趋势分析（依检验类型）（2018-2030）
  • 体内测试
    • 皮肤点刺试验
    • 皮内试验
    • 斑贴试验
  • 体外测试

第七章 竞争态势

  • 主要企业近期趋势及影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要企业热力图分析（2024年）
  • 公司简介
    • Thermo Fischer Scientific Inc.
    • Stallergenes Greer
    • HYCOR Biomedical
    • Minaris Medical America, Inc.
    • Omega Diagnostics Ltd
    • Lincoln Diagnostics, Inc.
    • Danaher Corporation
    • Alcon Inc.
    • AbbVie Inc.
    • Sanofi
    • Pfizer Inc.
    • Merck &Co., Inc.
Product Code: GVR-4-68040-650-0

Market Size & Trends:

The U.S. allergy diagnostics & therapeutics market size was valued at USD 10.86 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2030. The market is driven by the increasing prevalence of allergies among the population, and environmental factors such as increased pollution and lifestyle changes boost the demand for advanced solutions. The U.S. allergy diagnostics & therapeutics industry has witnessed a shift toward precision diagnostics. This evolution is fueled by groundbreaking innovations in molecular allergology and the widespread adoption of digital health tools.

Companies are actively expanding their allergy test portfolios, focusing on multiplex assays that enable the simultaneous detection of numerous allergens from a single patient sample. Furthermore, these diagnostic platforms are increasingly designed for seamless integration with Electronic Health Records (EHRs), a critical advancement that facilitates comprehensive patient data management and enhances clinical decision-making.

The industry is characterized by a high degree of innovation driven by ongoing research, technological advancements, and the development of more effective diagnostics and treatment options. In April 2025, Beckman Coulter Life Sciences announced the launch of its Next-Generation Basophil Activation Test (BAT). It is only for research purposes to expedite and improve allergy research.

The U.S. allergy diagnostics & therapeutics industry is also characterized by many new launches, strategic collaborations, and acquisitions among key players, emphasizing enhancing diagnostic accuracy and therapeutic efficacy. In January 2024, Inimmune Corporation and Intrommune Therapeutics announced a strategic partnership to develop a groundbreaking oral mucosal immunotherapy for peanut allergy.

U.S. Allergy Diagnostics & Therapeutics Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. allergy diagnostics & therapeutics market report based on type, allergen type, test type.

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Diagnostics
    • Instruments
    • Consumables
    • Services
  • Therapeutics
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-cholinergic
    • Immuno-modulators
    • Epinephrine
    • Immunotherapy
  • Allergen Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Food
    • Dairy Products
    • Poultry Product
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soys
    • Other Food Allergens
  • Inhaled
  • Drug
  • Other Allergens
  • Test Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • In vivo test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In vitro test

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Allergen Type
    • 1.2.3. Test Type
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test outlook
    • 2.2.2. Allergen Type outlook
    • 2.2.3. Test Type outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Allergy Diagnostics & Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Allergy Diagnostics & Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. U.S. Allergy Diagnostics & Therapeutics Market: Pipeline Analysis

Chapter 4. U.S. Allergy Diagnostics & Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. Allergy Diagnostics & Therapeutics Market: Type Movement Analysis
  • 4.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Type, 2018 To 2030 (USD Billion)
  • 4.4. Diagnostics
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Instruments
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Consumables
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Services
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Therapeutics
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Antihistamines
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Decongestants
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.4. Corticosteroids
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.5. Mast Cell Stabilizers
      • 4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.6. Leukotriene Inhibitors
      • 4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.7. Nasal Anti - Cholinergic
      • 4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.8. Immuno - Modulators
      • 4.5.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.9. Epinephrine
      • 4.5.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.10. Immunotherapy
      • 4.5.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis

  • 5.1. Allergen Type Segment Dashboard
  • 5.2. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Movement Analysis
  • 5.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, by Allergen Type, 2018 to 2030 (USD Billion)
  • 5.4. Food
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.2. Dairy Products
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.3. Poultry Product
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.4. Tree Nuts
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.5. Peanuts
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.6. Shellfish
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.7. Wheat
      • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.8. Soys
      • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.9. Other Food Allergens
      • 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Inhaled
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Drug
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Other Allergens
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Estimates & Trend Analysis

  • 6.1. Test Type Segment Dashboard
  • 6.2. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Movement Analysis
  • 6.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Test Type, 2018 to 2030 (USD Billion)
  • 6.4. In vivo test
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.2. Skin Prick Test
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.3. Intradermal Test
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.4. Patch Test
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. In vitro test
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fischer Scientific Inc.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Type benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Stallergenes Greer
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. HYCOR Biomedical
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Minaris Medical America, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Omega Diagnostics Ltd
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Lincoln Diagnostics, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Danaher Corporation
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Alcon Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. AbbVie Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Type benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Sanofi
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Type benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Pfizer Inc.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Type benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Merck & Co., Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Type benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. allergy diagnostics & therapeutics market, by type, 2018 - 2030 (USD Billion)
  • Table 3 U.S. allergy diagnostics & therapeutics market, by allergen type, 2018 - 2030 (USD Billion)
  • Table 4 U.S. allergy diagnostics & therapeutics market, by test type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Allergy Diagnostics & Therapeutics market: market outlook
  • Fig. 10 U.S. Allergy Diagnostics & Therapeutics competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. Allergy Diagnostics & Therapeutics market driver impact
  • Fig. 16 U.S. Allergy Diagnostics & Therapeutics market restraint impact
  • Fig. 17 U.S. Allergy Diagnostics & Therapeutics market strategic initiatives analysis
  • Fig. 18 U.S. Allergy Diagnostics & Therapeutics market: type movement analysis
  • Fig. 19 U.S. Allergy Diagnostics & Therapeutics market: type outlook and key takeaways
  • Fig. 20 Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 21 Instrument market estimates and forecast, 2018 - 2030
  • Fig. 22 Consumable market estimates and forecast, 2018 - 2030
  • Fig. 23 Service market estimates and forecast, 2018 - 2030
  • Fig. 24 Therapeutics market estimates and forecast, 2018 - 2030
  • Fig. 25 Antihistamines market estimates and forecast, 2018 - 2030
  • Fig. 26 Decongestants market estimates and forecast, 2018 - 2030
  • Fig. 27 Corticosteroids market estimates and forecast, 2018 - 2030
  • Fig. 28 Mast cell stabilizers market estimates and forecast, 2018 - 2030
  • Fig. 29 Leukotriene inhibitors market estimates and forecast, 2018 - 2030
  • Fig. 30 Nasal anti - cholinergic market estimates and forecast, 2018 - 2030
  • Fig. 31 Immuno-modulators market estimates and forecast, 2018 - 2030
  • Fig. 32 Epinephrine market estimates and forecast, 2018 - 2030
  • Fig. 33 Immunotherapy market estimates and forecast, 2018 - 2030
  • Fig. 34 U.S. Allergy Diagnostics & Therapeutics market: allergen type movement analysis
  • Fig. 35 U.S. Allergy Diagnostics & Therapeutics market: allergen type outlook and key takeaways
  • Fig. 36 Food market estimates and forecasts, 2018 - 2030
  • Fig. 37 Dairy products market estimates and forecasts,2018 - 2030
  • Fig. 38 Poultry products market estimates and forecasts,2018- 2030
  • Fig. 39 Tree nuts market estimates and forecasts,2018 - 2030
  • Fig. 40 Peanuts market estimates and forecasts,2018 - 2030
  • Fig. 41 Shellfish market estimates and forecasts,2018 - 2030
  • Fig. 42 Soys market estimates and forecasts,2018 - 2030
  • Fig. 43 Other food allergens market estimates and forecasts,2018 - 2030
  • Fig. 44 Inhaled market estimates and forecasts,2018 - 2030
  • Fig. 45 Drug market estimates and forecasts,2018 - 2030
  • Fig. 46 Other allergens market estimates and forecasts,2018 - 2030
  • Fig. 47 U.S. Allergy Diagnostics & Therapeutics market: test type movement analysis
  • Fig. 48 U.S. Allergy Diagnostics & Therapeutics market: test type outlook and key takeaways
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030
  • Fig. 50 In vivo test market estimates and forecasts, 2018 - 2030
  • Fig. 51 Skin prick test market estimates and forecasts, 2018 - 2030
  • Fig. 52 Intradermal market estimates and forecasts, 2018 - 2030
  • Fig. 53 Patch test market estimates and forecasts,2018 - 2030
  • Fig. 54 In vitro test market estimates and forecasts,2018 - 2030